| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |